News

The Alpha variant of SARS-CoV-2 – the first variant of concern – evolved mutations that allowed it to more efficiently suppress the immune system’s early response to infection, according to a new study led by scientists at the UC San Francisco’s Quantitative Biosciences Institute (QBI) and

For patients undergoing facial reconstruction following disfiguring cancer operations, a new technique pioneered by surgeons at UC San Francisco may enable them to look more like their former selves. Typically, the use of skin from other parts of the body for facial skin reconstruction, has led to

Experts from UCSF Health will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the world’s largest and most prestigious breast cancer conference. This year’s meeting will be held Dec. 7-10. The international conference is expected to draw 8,000 attendees

UC San Francisco has launched the Baszucki Lymphoma Therapeutics Initiative to increase the effectiveness and availability of chimeric antigen receptor T-cell (CAR T) therapy for lymphoma patients. Jan Ellison Baszucki and her husband, Roblox CEO David Baszucki, gifted $6 million over five years to

Researchers at UC San Francisco and UCLA continue to study prostate-specific membrane antigen PET imaging, or PSMA PET, to provide a more effective imaging test for men who have prostate cancer. Last year, this collaboration on a clinical trial led to U.S. Food and Drug Administration (FDA) approval

For 14 years oncology dietitian Greta Macaire, RD, MA, has provided nutrition support to cancer patients before, during, and after treatment. She creates tailored nutrition plans that support individual goals and that optimize wellness and quality of life by taking into account a person's overall